Cannabis Dependency Recovery
Recovery from cannabis dependency starts with a clinical assessment. Cannabis use disorder (CUD) is a DSM-5 diagnosis. It requires at least 2 of 11 criteria within 12 months. The criteria include using more than planned, failed attempts to cut back, cravings, tolerance, and use that harms work, school, or family. About 3 in 10 people who use cannabis develop the disorder, per the National Institute on Drug Abuse. The rate is about 1 in 6 for people who start before age 18.
treatment for cannabis dependence
No medication holds FDA approval for CUD. Behavioral therapy is the base of treatment. Withdrawal is a real syndrome and is listed in the DSM-5.
Withdrawal Timeline
Symptoms start 24 to 72 hours after the last use. They peak in the first week. Most fade in 1 to 2 weeks. Sleep problems can last 30 days or more.
Cannabis Addiction Therapy: Effective Treatments and Tips
- Irritability, anger, or aggression
- Trouble sleeping, vivid dreams
- Reduced appetite, weight loss
- Restlessness
- Depressed mood
- Cravings
- Headache, sweating, chills, stomach pain
Heavy daily use and high-THC products raise symptom intensity. THC concentration in cannabis products rose from under 4% in 1995 to about 15% in 2018 in samples tested by NIDA.
Treatment Options
- Cognitive behavioral therapy (CBT): 6 to 12 sessions. Targets triggers, thoughts, and coping skills.
- Motivational enhancement therapy (MET): 2 to 4 sessions. Builds internal reasons to change.
- Contingency management: rewards for negative drug tests. This holds the strongest trial evidence for cannabis.
- Peer support: 12-step groups and SMART Recovery. Free and available in most metro areas.
SAMHSA National Helpline: 1-800-662-4357. Free, confidential, 24 hours. Call or text 988 for a mental health crisis. Inpatient care is an option for co-occurring disorders or housing loss.
Relapse Rates
NIDA puts relapse for substance use disorders at 40% to 60%. That range matches relapse rates for diabetes and hypertension. A return to use is a treatment event, not proof of failure. Most people who quit need more than one attempt.
What CBD Does and Does Not Do
Epidiolex, a purified CBD drug, has FDA approval for seizures in Dravet and Lennox-Gastaut syndromes. It has no approval for cannabis use disorder. A small number of trials tested CBD for CUD. Sample sizes were small and results were mixed. No CBD product is approved to treat addiction.
Label accuracy is a separate issue. A 2023 review of CBD products found that many did not match the amount on the label. A certificate of analysis (COA) from a third-party lab lists cannabinoid content and tests for heavy metals, pesticides, and residual solvents. Ask for a COA per batch before you buy.
Questions for a Provider
- Which DSM-5 criteria do I meet?
- Do I have a co-occurring condition such as anxiety or depression?
- Which therapy has the best fit and how many sessions?
- What is the plan for sleep and appetite in week one?
- What warning signs mean I should call between sessions?